Modifying the shape of IRAK-M, a protein that controls inflammation, can significantly reduce the clinical progression of inflammation and colon cancer in pre-clinical animal models.
Modifying the shape of IRAK-M, a protein that controls inflammation, can significantly reduce the clinical progression of inflammation and colon cancer in pre-clinical animal models.